Safety Shot President Jordan Schur Invests an Additional $3.4 Million in the Company Through His Family Fund, Core 4 Capital Corp.
Safety Shot, Inc. (Nasdaq: SHOT) announced that its President, Jordan Schur, has invested an additional $3.4 million in the company through his family investment group, Core 4 Capital Corp. This investment comes in the form of a private placement, with the issuance of 3,370,787 shares at $0.89 per share and 3,370,767 warrants at $0.125 per warrant. Combined with previous investments, Core 4 has now invested a total of $9.4 million in Safety Shot.
Schur expressed enthusiasm about the company's progress, citing recent clinical trial results that demonstrate Safety Shot's effectiveness in lowering Blood Alcohol Content and alleviating hangover symptoms. The company plans to use the proceeds for working capital, general corporate purposes, and to support the growth of the Safety Shot brand.
Safety Shot, Inc. (Nasdaq: SHOT) ha annunciato che il suo Presidente, Jordan Schur, ha investito ulteriori 3,4 milioni di dollari nell'azienda attraverso il suo gruppo di investimento familiare, Core 4 Capital Corp. Questo investimento avviene sotto forma di private placement, con l'emissione di 3.370.787 azioni a 0,89 dollari per azione e 3.370.767 warrant a 0,125 dollari per warrant. Combinato con gli investimenti precedenti, Core 4 ha ora investito un totale di 9,4 milioni di dollari in Safety Shot.
Schur ha espresso entusiasmo riguardo ai progressi dell’azienda, citando i recenti risultati delle sperimentazioni cliniche che dimostrano l'efficacia di Safety Shot nel ridurre il contenuto di alcol nel sangue e nel alleviare i sintomi post-sbornia. L'azienda prevede di utilizzare i proventi per il capitale circolante, scopi aziendali generali e per supportare la crescita del marchio Safety Shot.
Safety Shot, Inc. (Nasdaq: SHOT) anunció que su Presidente, Jordan Schur, ha invertido 3.4 millones de dólares adicionales en la empresa a través de su grupo de inversión familiar, Core 4 Capital Corp. Esta inversión se realiza en forma de colocación privada, con la emisión de 3,370,787 acciones a 0.89 dólares por acción y 3,370,767 warrants a 0.125 dólares por warrant. Junto con inversiones anteriores, Core 4 ha invertido ahora un total de 9.4 millones de dólares en Safety Shot.
Schur expresó su entusiasmo por el progreso de la empresa, citando resultados recientes de ensayos clínicos que demuestran la eficacia de Safety Shot en la reducción del contenido de alcohol en sangre y en el alivio de los síntomas de la resaca. La empresa planea utilizar los ingresos para capital de trabajo, fines corporativos generales y para apoyar el crecimiento de la marca Safety Shot.
Safety Shot, Inc. (Nasdaq: SHOT)는 사장인 Jordan Schur가 가족 투자 그룹인 Core 4 Capital Corp.를 통해 회사에 추가로 340만 달러를 투자했다고 발표했습니다. 이 투자는 사모 배정을 통해 이루어지며, 3,370,787주가 주당 0.89달러에 발행되고 3,370,767개의 워런트가 워런트당 0.125달러에 발행됩니다. 이전 투자와 합쳐서 Core 4는 이제 Safety Shot에 총 940만 달러를 투자했습니다.
Schur는 회사의 발전에 대한 열정을 표명하며, 최근 임상 시험 결과가 Safety Shot이 혈중 알코올 농도를 낮추고 숙취 증상을 완화하는 데 효과적임을 입증하고 있다고 언급했습니다. 회사는 수익금을 운영 자본, 일반 기업 용도 및 Safety Shot 브랜드의 성장을 지원하는 데 사용할 계획입니다.
Safety Shot, Inc. (Nasdaq: SHOT) a annoncé que son Président, Jordan Schur, a investi 3,4 millions de dollars supplémentaires dans l'entreprise par le biais de son groupe d'investissement familial, Core 4 Capital Corp. Cet investissement se fait sous forme de placement privé, avec l'émission de 3 370 787 actions à 0,89 dollar par action et 3 370 767 bons de souscription à 0,125 dollar par bon de souscription. Combiné avec les investissements précédents, Core 4 a maintenant investi un total de 9,4 millions de dollars dans Safety Shot.
Schur a exprimé son enthousiasme quant aux progrès de l'entreprise, en citant les résultats récents d'essais cliniques qui démontrent l'efficacité de Safety Shot pour réduire le taux d'alcool dans le sang et soulager les symptômes de la gueule de bois. L'entreprise prévoit d'utiliser les fonds pour le fonds de roulement, des objectifs d'entreprise généraux et pour soutenir la croissance de la marque Safety Shot.
Safety Shot, Inc. (Nasdaq: SHOT) gab bekannt, dass der Präsident, Jordan Schur, zusätzlich 3,4 Millionen Dollar in das Unternehmen durch seine Familienstiftung, Core 4 Capital Corp., investiert hat. Diese Investition erfolgt in Form einer Privatplatzierung mit der Ausgabe von 3.370.787 Aktien zu je 0,89 Dollar pro Aktie und 3.370.767 Warrant zu je 0,125 Dollar pro Warrant. Zusammengerechnet hat Core 4 nun insgesamt 9,4 Millionen Dollar in Safety Shot investiert.
Schur äußerte seine Begeisterung über den Fortschritt des Unternehmens und verwies auf die jüngsten Ergebnisse klinischer Studien, die die Wirksamkeit von Safety Shot bei der Senkung des Blutalkoholgehalts und der Linderung von Kater-Symptomen zeigen. Das Unternehmen plant, die Einnahmen für Betriebskapital, allgemeine Unternehmenszwecke sowie zur Unterstützung des Wachstums der Marke Safety Shot zu verwenden.
- Additional $3.4 million investment from company President Jordan Schur
- Total investment from Core 4 Capital Corp. reaches $9.4 million
- Clinical trial proves product's effectiveness in lowering Blood Alcohol Content
- Funds to be used for working capital and brand growth
- None.
This $3.4 million investment from Safety Shot's President is a strong vote of confidence in the company's future. The total investment of
The clinical trial results from the Center for Applied Health Sciences are intriguing. Safety Shot's product demonstrating the ability to lower Blood Alcohol Content and alleviate hangover symptoms could be groundbreaking in the health and wellness sector. However, it's important to see the full study details, including sample size, methodology and statistical significance. The metabolism support claim needs further explanation and peer review. If these results hold up under scrutiny, Safety Shot could potentially disrupt the alcohol consumption market. Investors should watch for FDA reactions, potential partnerships with alcohol brands and consumer adoption rates to gauge the product's true market potential.
Safety Shot's product sits at an interesting intersection of health, wellness and the alcohol industry. The market for hangover remedies and alcohol-related health products is growing, but it's also crowded and skeptical. The clinical trial results could be a key differentiator if marketed effectively. The $9.4 million total investment suggests a significant marketing and distribution push may be coming. Investors should watch for the go-to-market strategy, including target demographics, pricing and distribution channels. The company's ability to navigate regulatory challenges and build consumer trust will be crucial. Early adoption rates and repeat purchase data will be key indicators of product viability and long-term growth potential.
JUPITER, FL, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (the “Company” or “Safety Shot”) is pleased to announce that Safety Shot President Jordan Schur has invested in a
In addition to gross proceeds of
“I have seen amazing progress in this Company since I joined approximately six months ago,” said Schur. “The recent release of our clinical trial conducted by the Center for Applied Health Sciences shows that our product is clinically proven to lower Blood Alcohol Content by supporting its metabolism and alleviates the next morning symptoms of excessive drinking. I couldn’t be more excited about the Company’s future,” continued Schur.
The Company intends to use the net proceeds from the Offering as working capital, towards general corporate purposes, and to fund the continued development and growth of the Safety Shot brand. For more details of the investment, please see the Company’s Current Report on Form 8-k to be filed on September 4, 2024.
About Safety Shot, Inc.
Safety Shot, Inc., a wellness and dietary supplement company, has developed Safety Shot, the first patented wellness product on Earth that lowers blood alcohol content by supporting its metabolism, while boosting clarity, energy, and overall mood. Safety Shot is available for purchase online at DrinkSafetyShot.com and Amazon. The Company is introducing business-to-business sales of Safety Shot to distributors, retailers, restaurants, and bars throughout 2024.
Forward-Looking Statements
This press release includes certain disclosures that contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 about us and our industry that involve substantial risks and uncertainties. All statements other than statements of historical facts contained in this press release, including statements regarding Safety Shot’s ability to develop and commercialize a product that lowers blood alcohol content, the timing, progress and results of non-clinical studies and clinical trials, including our product development plans and strategies, Safety Shot’s future results of operations or financial condition, business strategy and plans, and objectives of management for future operations, are forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” or “would” or the negative of these words or other similar terms or expressions. Forward-looking statements are based on Safety Shot’s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. Factors that could cause actual results to differ include, but are not limited to, our ability to comply with applicable U.S. and foreign laws, rules, and regulations, product liability claims, our ability to develop and market safely.
Connect with Safety Shot: Website: www.DrinkSafetyShot.com Twitter: @SafetyShotInc Instagram: @SafetyShotInc Facebook: Safety Shot, Inc.
Media and Investor Contact:
Autumn Communications
Jessica Weinberger
Phone: 916-677-7495
Email: shot@autumncommunications.com
Medon Michaelides
Investor Relations
Phone: 561-244-7100
Email: investors@drinksafetyshot.com
FAQ
How much did Safety Shot (SHOT) raise in its recent private placement?
What was the share price for Safety Shot's (SHOT) recent private placement on September 4, 2024?
What did Safety Shot's (SHOT) clinical trial results show?
How much has Core 4 Capital Corp. invested in total in Safety Shot (SHOT)?
